Why Invest?

  • Diversified pipeline of potential first-in-class products with multiple near-term staged catalysts
  • Attractive multi-billion-dollar opportunities in adjunctive cancer care, infectious disease and gastrointestinal disease
  • Strong research partnerships to advance the pipeline
  • Robust balance sheet to support pipeline development and invest in long-term growth
  • Seasoned leadership with successful execution-focused track record

Citius is guided by three principles in our mission to deliver best-in-class therapies for patients with critical unmet needs.

  • Advance therapies with unique commercial advantages
  • Invest in assets with differentiated upside potential
  • Create long-term sustainable value for shareholders
Pillars of CTXR Strategy